Indicated for: hypertension
Substance: irbesartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)
ATC: C09DA04 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)
The combination of irbesartan and hydrochlorothiazide is used to treat essential hypertension in patients who do not respond adequately to monotherapy. Irbesartan is an angiotensin II receptor antagonist that helps relax blood vessels, while hydrochlorothiazide is a diuretic that reduces fluid volume in the body, thereby lowering blood pressure.
The medication is taken orally, usually once daily, as directed by a doctor.
Side effects may include dizziness, fatigue, nausea, or electrolyte imbalances. In rare cases, severe allergic reactions or kidney dysfunction may occur.
Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.